AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a USD 118 billion takeover approach from rival drugmaker Pfizer two months ago.
from Zee News : Business http://ift.tt/1qMwWfq
via IFTTT
from Zee News : Business http://ift.tt/1qMwWfq
via IFTTT
No comments:
Post a Comment